444 related articles for article (PubMed ID: 22054347)
1. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats.
Wu L; Olverling A; Huang Z; Jansson L; Chao H; Gao X; Sjöholm Å
Clin Sci (Lond); 2012 Apr; 122(8):375-84. PubMed ID: 22054347
[TBL] [Abstract][Full Text] [Related]
2. Ethanol acutely stimulates islet blood flow, amplifies insulin secretion, and induces hypoglycemia via nitric oxide and vagally mediated mechanisms.
Huang Z; Sjöholm A
Endocrinology; 2008 Jan; 149(1):232-6. PubMed ID: 17916634
[TBL] [Abstract][Full Text] [Related]
3. Effects of tetramethylpyrazine phosphate on pancreatic islet microcirculation in SD rats.
Xu X; Wu L; Lu ZQ; Xia P; Zhu XP; Gao X
J Endocrinol Invest; 2018 Apr; 41(4):411-419. PubMed ID: 28918509
[TBL] [Abstract][Full Text] [Related]
4. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
Parkes DG; Pittner R; Jodka C; Smith P; Young A
Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
[TBL] [Abstract][Full Text] [Related]
5. Acute regulation of pancreatic islet microcirculation and glycaemia by telmisartan and ramipril: discordant effects between normal and type 2 diabetic rats.
Olverling A; Huang Z; Nyström T; Sjöholm Å
Clin Sci (Lond); 2013 Nov; 125(9):433-8. PubMed ID: 23713675
[TBL] [Abstract][Full Text] [Related]
6. The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
Sahraoui A; Winzell MS; Gorman T; Smith DM; Skrtic S; Hoeyem M; Abadpour S; Johansson L; Korsgren O; Foss A; Scholz H
PLoS One; 2015; 10(3):e0121204. PubMed ID: 25793295
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 and islet lipolysis.
Sörhede Winzell M; Ahrén B
Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
[TBL] [Abstract][Full Text] [Related]
8. [Influences of exendin-4 on the secretion function of islet beta cells from rats in the early stage of severe scald].
Zhao DX; Ma L; Shen ZA; Li DW; Shang YR; Yin K; Cheng WF; Wang X; Liu ZX
Zhonghua Shao Shang Za Zhi; 2016 Dec; 32(12):752-758. PubMed ID: 28043300
[No Abstract] [Full Text] [Related]
9. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age.
Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B
Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477
[TBL] [Abstract][Full Text] [Related]
10. Gender-specific regulation of pancreatic islet blood flow, insulin levels and glycaemia in spontaneously diabetic Goto-Kakizaki rats.
Huang Z; Jansson L; Sjöholm A
Clin Sci (Lond); 2008 Jul; 115(1):35-42. PubMed ID: 18205625
[TBL] [Abstract][Full Text] [Related]
11. Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4.
Tourrel C; Bailbe D; Lacorne M; Meile MJ; Kergoat M; Portha B
Diabetes; 2002 May; 51(5):1443-52. PubMed ID: 11978641
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
[TBL] [Abstract][Full Text] [Related]
13. Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.
Winzell MS; Ahrén B
J Mol Endocrinol; 2008 Feb; 40(2):93-100. PubMed ID: 18234911
[TBL] [Abstract][Full Text] [Related]
14. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.
Schirra J; Nicolaus M; Roggel R; Katschinski M; Storr M; Woerle HJ; Göke B
Gut; 2006 Feb; 55(2):243-51. PubMed ID: 15985560
[TBL] [Abstract][Full Text] [Related]
15. Effects of glucagon-like peptide-1-(7-36)-amide on pancreatic islet and intestinal blood perfusion in Wistar rats and diabetic GK rats.
Svensson AM; Ostenson CG; Efendic S; Jansson L
Clin Sci (Lond); 2007 Jun; 112(6):345-51. PubMed ID: 17087662
[TBL] [Abstract][Full Text] [Related]
16. Exenatide can reduce glucose independent of islet hormones or gastric emptying.
Ionut V; Zheng D; Stefanovski D; Bergman RN
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E269-77. PubMed ID: 18492781
[TBL] [Abstract][Full Text] [Related]
17. Total parenteral nutrition-stimulated activity of inducible nitric oxide synthase in rat pancreatic islets is suppressed by glucagon-like peptide-1.
Salehi A; Ekelund M; Lundquist I
Horm Metab Res; 2003 Jan; 35(1):48-54. PubMed ID: 12669271
[TBL] [Abstract][Full Text] [Related]
18. The effect of glucagon-like peptide-1 in the management of diabetes mellitus: cellular and molecular mechanisms.
Lotfy M; Singh J; Rashed H; Tariq S; Zilahi E; Adeghate E
Cell Tissue Res; 2014 Nov; 358(2):343-58. PubMed ID: 25115772
[TBL] [Abstract][Full Text] [Related]
19. Early intervention with liraglutide improves glucose tolerance without affecting islet microcirculation in young Goto-Kakizaki rats.
Wu L; Olverling A; Fransson L; Ortsäter H; Kappe C; Gao X; Sjöholm A
Regul Pept; 2012 Aug; 177(1-3):92-6. PubMed ID: 22587909
[TBL] [Abstract][Full Text] [Related]
20. In vivo treatment with glucagon-like peptide 1 promotes the graft function of fetal islet-like cell clusters in transplanted mice.
Suen PM; Li K; Chan JC; Leung PS
Int J Biochem Cell Biol; 2006; 38(5-6):951-60. PubMed ID: 16172015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]